Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study.

Dae-Myoung YangDavid A PalmaKeith KwanAlexander V LouieRichard MalthanerDalilah FortinGeorge B RodriguesBrian P YaremkoJoanna LabaStewart GaedeAndrew WarnerRichard InculetTing-Yim Lee

Published in: Radiation oncology (London, England) (2021)

MISSILE-NSCLC, NCT02136355 (ClinicalTrials.gov). Registered May 8, 2014, https://clinicaltrials.gov/ct2/show/NCT02136355.

Keyphrases

positron emission tomography
contrast enhanced
computed tomography
radiation therapy
image quality
dual energy
pet ct
pet imaging
small cell lung cancer
magnetic resonance imaging
brain metastases
high resolution
advanced non small cell lung cancer
double blind
squamous cell carcinoma
radiation induced